APYX Past Earnings image   This APYX past earnings page last updated 5/16/2022
APYX Past Earnings
Data adjusted for APYX split history

PeriodPast Earnings DateGAAP
Q1 20225/12/2022-0.170
Q4 20213/17/2022-0.060
Q3 202111/11/2021-0.120
Q2 20218/12/2021-0.120
Q1 20215/12/2021-0.140
Q4 20203/31/2021-0.040
Q3 202011/9/2020-0.110
Q2 20208/10/2020-0.140
Q1 20205/11/2020-0.200
Q4 20193/16/2020-0.160
Q3 201911/11/2019-0.130
Q2 20198/7/2019-0.130
Q1 20195/8/2019-0.140
Q4 20183/13/2019-0.1
Q3 201811/1/2018-0.01
Q2 20188/1/2018-0.01
Q1 20185/14/2018-0.03
Q4 20173/12/20180.02
Q3 201711/2/2017-0.04
Q2 20178/2/2017-0.04
Q1 20175/15/2017-0.06
Q4 20163/9/2017-0.04
Q3 201610/26/2016-0.01
Q2 20168/1/2016-0.02
Q1 20165/11/2016-0.07
Q4 20153/17/2016-0.05
Q3 201511/4/2015-0.07
Q2 20158/6/2015-0.06
Q1 20155/8/2015-0.14
Q4 20142/27/2015-0.04
Q3 201411/6/2014-0.17
Q2 20148/5/2014-0.07
Q1 20145/15/2014-0.55
Q4 20133/31/2014-0.14
Q3 201311/14/2013-0.02
Q2 20138/14/20130.06
Q1 20135/15/2013-0.02
Q4 20124/1/20130.02
APYX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/12/20220.01B
Q4 20213/17/20220.02B
Q3 202111/11/20210.01B
Q2 20218/12/20210.01B
Q1 20215/12/20210.01B
Q4 20203/31/20210.01B
Q3 202011/9/20200.01B
Q2 20208/10/20200.00B
Q1 20205/11/20200.00B
Q4 20193/16/20200.01B
Q3 201911/11/20190.01B
Q2 20198/7/20190.01B
Q1 20195/8/20190.01B
Q4 20183/13/20195.93M
Q3 201811/1/20183.67M
Q2 20188/1/201811.47M
Q1 20185/14/20189.92M
Q4 20173/12/201811.35M
Q3 201711/2/20179.35M
Q2 20178/2/20179.80M
Q1 20175/15/20178.39M
Q4 20163/9/20179.49M
Q3 201610/26/201610.06M
Q2 20168/1/20169.29M
Q1 20165/11/20167.78M
Q4 20153/17/20168.29M
Q3 201511/4/20157.82M
Q2 20158/6/20157.27M
Q1 20155/8/20156.13M
Q4 20142/27/20157.47M
Q3 201411/6/20146.80M
Q2 20148/5/20146.95M
Q1 20145/15/20146.58M
Q4 20133/31/20146.10M
Q3 201311/14/20135.79M
Q2 20138/14/20136.04M
Q1 20135/15/20135.70M
Q4 20124/1/20136.83M
Quotes delayed 20 minutes

Email EnvelopeFree APYX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Apyx Medical (APYX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AQST Historical Earnings
ARAV Historical Earnings
ARAY Historical Earnings
ARCT Historical Earnings
ARDS Historical Earnings
ARDX Historical Earnings
ARNA Historical Earnings
ARPO Historical Earnings
ARQT Historical Earnings
ARTL Historical Earnings

APYX Past Earnings Q&A

What was the best and worst APYX past earnings results?
For Apyx Medical, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest APYX past earnings result in our data set was 0.06/share posted in Q2 2013, while the lowest was in Q1 2014 when APYX posted -0.55/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when APYX reported 0.02B in revenue, while the quarter with the lowest revenue in our data set was Q3 2018 at 3.67M of revenue.

  Suggested answer: There are 38 APYX past earnings results in our data set.

On this page we presented the APYX past earnings date information for Apyx Medical. Reviewing that APYX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2013, when APYX posted gaap of 0.06/share. Meanwhile the lowest APYX past earnings result was in Q1 2014, when APYX posted gaap of -0.55/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when APYX reported 0.02B in revenue, while the smallest revenue quarter was Q3 2018 when APYX reported 3.67M in revenue.

Any self directed investor doing their due diligence on APYX or any other given stock can benefit from researching all of the Apyx Medical past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Apyx Medical past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for APYX. Thanks for visiting, and the next time you need to research APYX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: EPAM market cap history, Institutional Holders of VRIG, Top Ten Hedge Funds Holding ROOF.

 

APYX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.